Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Biochemical Genetics|June 4, 2023
A Novel Platinum Resistance-Related Immune Gene Signature for Overall Survival Prediction in Patients with Ovarian CancerChenfei Zhou, Junnan Ma, Wanjun Luo, et al.
Medical Oncology (Northwood, London, England)|January 12, 2013
AEG-1 expression characteristics in human non-small cell lung cancer and its relationship with apoptosisZun-Fu Ke, Xiaopeng Mao, Cao Zeng, et al.
Bioscience Reports|November 5, 2017
Up-regulation of long non-coding RNA SNHG20 promotes ovarian cancer progression via Wnt/β-catenin signalingShanyang He, Yunhe Zhao, Xiaoping Wang, et al.
Gynecologic Oncology|October 12, 2016
MiR-760 overexpression promotes proliferation in ovarian cancer by downregulation of PHLPP2 expressionYanbin Liao, Yalan Deng, Jun Liu, et al.
Bioscience Reports|February 26, 2020
Efficacy and safety of PARP inhibitors as the maintenance therapy in ovarian cancer: a meta-analysis of nine randomized controlled trialsFengping Shao, Jun Liu, Yaoyun Duan, et al.
Molecular and Cellular Biochemistry|June 23, 2025
High IGFL2 regulates ovarian cancer progression and the tumor immune microenvironment via the Warburg effectZhizai Chen, Dalong Song, Shuting Huang, et al.
Aging|March 11, 2021
PARP inhibitors in breast and ovarian cancer with BRCA mutations: a meta-analysis of survivalFengping Shao, Yaoyun Duan, Yunhe Zhao, et al.
Molecular Therapy Oncolytics|March 19, 2021
PTOV1 promotes cisplatin-induced chemotherapy resistance by activating the nuclear factor kappa B pathway in ovarian cancerHongwei Shen, Bing Liao, Zhiyong Wan, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 6, 2017
The oncogenic Golgi phosphoprotein 3 like overexpression is associated with cisplatin resistance in ovarian carcinoma and activating the NF-κB signaling pathwayShanyang He, Gang Niu, Jianhong Shang, et al.
BMC Cancer|October 6, 2017
MiR-216b inhibits cell proliferation by targeting FOXM1 in cervical cancer cells and is associated with better prognosisShanyang He, Bing Liao, Yalan Deng, et al.
Pageof 4